ESPR- Esperion Therapeutics, Inc.

Name: Esperion Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Koenig Sheldon L.	1.47M	$4.65M	-
CFO	Halladay Benjamin	467.5K	$1.48M	-
Other	Looker Benjamin	385.9K	$1.22M	-
Other	Harlow John B. Jr.	380.0K	$1.20M	-
Dir	Carroll J Martin	177.5K	$561.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 17, 2024	Foody Joanne M.73	Chief Medical Officer	Sell	917	$2.60	$2,383.28	-0.3%	-18.7%	-52.7%
Jun 18, 2024	Foody Joanne M.73	Chief Medical Officer	Sell	3,285	$2.87	$9,418.10	-1.2%	-35.3%	-59.6%
Jun 18, 2024	Warren Eric60	Chief Commercial Officer	Sell	2,540	$2.86	$7,254.24	-1.5%	-35.3%	-59.6%
May 17, 2024	Warren Eric60	Chief Commercial Officer	Sell	192	$2.48	$476.74	-0.1%	-16.5%	-66.0%
Sep 20, 2023	Warren Eric60	Chief Commercial Officer	Sell	742	$1.25	$923.79	-1.1%	+103.5%	+52.2%
Aug 18, 2023	Warren Eric60	Chief Commercial Officer	Sell	243	$1.41	$343.60	-0.4%	-23.4%	+35.2%
Jul 19, 2023	Warren Eric60	Chief Commercial Officer	Sell	106	$1.59	$168.01	-0.2%	-38.8%	+59.1%
Jun 21, 2023	Warren Eric60	Chief Commercial Officer	Sell	603	$1.48	$894.25	-0.9%	-12.4%	+61.8%
May 17, 2023	Warren Eric60	Chief Commercial Officer	Sell	219	$1.62	$355.66	-0.3%	-6.8%	+47.2%
May 11, 2023	Carroll J Martin53	Director	Buy	31,500	$1.55	$48,830.58	+171.1%	+6.7%	+47.0%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC